Literature DB >> 29158590

Disseminated breast tumour cells: biological and clinical meaning.

Klaus Pantel1, Daniel F Hayes2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29158590     DOI： 10.1038/nrclinonc.2017.174

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.

Authors:  Isaac Garcia-Murillas; Gaia Schiavon; Britta Weigelt; Charlotte Ng; Sarah Hrebien; Rosalind J Cutts; Maggie Cheang; Peter Osin; Ashutosh Nerurkar; Iwanka Kozarewa; Javier Armisen Garrido; Mitch Dowsett; Jorge S Reis-Filho; Ian E Smith; Nicholas C Turner
Journal:  Sci Transl Med       Date:  2015-08-26       Impact factor: 17.956

2.  Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.

Authors:  Harold J Burstein; Sarah Temin; Holly Anderson; Thomas A Buchholz; Nancy E Davidson; Karen E Gelmon; Sharon H Giordano; Clifford A Hudis; Diana Rowden; Alexander J Solky; Vered Stearns; Eric P Winer; Jennifer J Griggs
Journal:  J Clin Oncol       Date:  2014-05-27       Impact factor: 44.544

3.  Persistence of disseminated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse--a European pooled analysis.

Authors:  Wolfgang Janni; Florian D Vogl; Gro Wiedswang; Marit Synnestvedt; Tanja Fehm; Julia Jückstock; Elin Borgen; Brigitte Rack; Stephan Braun; Harald Sommer; Erich Solomayer; Klaus Pantel; Jahn Nesland; Klaus Friese; Bjørn Naume
Journal:  Clin Cancer Res       Date:  2011-03-17       Impact factor: 12.531

4.  A pooled analysis of bone marrow micrometastasis in breast cancer.

Authors:  Stephan Braun; Florian D Vogl; Bjørn Naume; Wolfgang Janni; Michael P Osborne; R Charles Coombes; Günter Schlimok; Ingo J Diel; Bernd Gerber; Gerhard Gebauer; Jean-Yves Pierga; Christian Marth; Daniel Oruzio; Gro Wiedswang; Erich-Franz Solomayer; Günther Kundt; Barbara Strobl; Tanja Fehm; George Y C Wong; Judith Bliss; Anne Vincent-Salomon; Klaus Pantel
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

5.  Circulating tumor cells in patients with breast cancer dormancy.

Authors:  Songdong Meng; Debasish Tripathy; Eugene P Frenkel; Sanjay Shete; Elizabeth Z Naftalis; James F Huth; Peter D Beitsch; Marilyn Leitch; Susan Hoover; David Euhus; Barbara Haley; Larry Morrison; Timothy P Fleming; Dorothee Herlyn; Leon W M M Terstappen; Tanja Fehm; Thomas F Tucker; Nancy Lane; Jianqiang Wang; Jonathan W Uhr
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

6.  20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Authors:  Hongchao Pan; Richard Gray; Jeremy Braybrooke; Christina Davies; Carolyn Taylor; Paul McGale; Richard Peto; Kathleen I Pritchard; Jonas Bergh; Mitch Dowsett; Daniel F Hayes
Journal:  N Engl J Med       Date:  2017-11-09       Impact factor: 91.245

7.  Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer.

Authors:  Wolfgang J Janni; Brigitte Rack; Leon W M M Terstappen; Jean-Yves Pierga; Florin-Andrei Taran; Tanja Fehm; Carolyn Hall; Marco R de Groot; François-Clement Bidard; Thomas W P Friedl; Peter A Fasching; Sara Y Brucker; Klaus Pantel; Anthony Lucci
Journal:  Clin Cancer Res       Date:  2016-01-05       Impact factor: 12.531

Review 8.  Detection, clinical relevance and specific biological properties of disseminating tumour cells.

Authors:  Klaus Pantel; Ruud H Brakenhoff; Burkhard Brandt
Journal:  Nat Rev Cancer       Date:  2008-05       Impact factor: 60.716

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Authors:  C Davies; J Godwin; R Gray; M Clarke; D Cutter; S Darby; P McGale; H C Pan; C Taylor; Y C Wang; M Dowsett; J Ingle; R Peto
Journal:  Lancet       Date:  2011-07-28       Impact factor: 79.321
  10 in total
  15 in total

1.  11th International Symposium on Minimal Residual Cancer (ISMRC): 3-5 May 2018, Montpellier, France.

Authors:  Catherine Alix-Panabières; Klaus Pantel
Journal:  Clin Exp Metastasis       Date:  2018-07-06       Impact factor: 5.150

Review 2.  Liquid biopsy enters the clinic - implementation issues and future challenges.

Authors:  Michail Ignatiadis; George W Sledge; Stefanie S Jeffrey
Journal:  Nat Rev Clin Oncol       Date:  2021-01-20       Impact factor: 66.675

3.  Fast, Reusable, Cell Uniformly Distributed Membrane Filtration Device for Separation of Circulating Tumor Cells.

Authors:  Jintao Han; Chunyang Lu; Mengzhu Shen; Xiaoyi Sun; Xiaodong Mo; Gen Yang
Journal:  ACS Omega       Date:  2022-06-08

4.  Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor.

Authors:  Paolo Bonvini; Elisabetta Rossi; Angelica Zin; Mariangela Manicone; Riccardo Vidotto; Antonella Facchinetti; Lucia Tombolan; Maria Carmen Affinita; Luisa Santoro; Rita Zamarchi; Gianni Bisogno
Journal:  Front Pediatr       Date:  2021-04-29       Impact factor: 3.418

5.  Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients.

Authors:  Aleksandra Markiewicz; Anna Nagel; Jolanta Szade; Hanna Majewska; Jaroslaw Skokowski; Barbara Seroczynska; Tomasz Stokowy; Marzena Welnicka-Jaskiewicz; Anna J Zaczek
Journal:  Transl Oncol       Date:  2018-04-16       Impact factor: 4.243

6.  Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer.

Authors:  Lisa König; Fabian D Mairinger; Oliver Hoffmann; Ann-Kathrin Bittner; Kurt W Schmid; Rainer Kimmig; Sabine Kasimir-Bauer; Agnes Bankfalvi
Journal:  BMC Cancer       Date:  2019-02-04       Impact factor: 4.430

7.  Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse.

Authors:  Chidananda M Siddappa; Sreeraj G Pillai; Jackie Snider; Patsy Alldredge; Kathyrn Trinkaus; Mark A Watson; Rebecca Aft
Journal:  Breast Cancer Res Treat       Date:  2019-08-20       Impact factor: 4.872

8.  CXCR4 and JUNB double-positive disseminated tumor cells are detected frequently in breast cancer patients at primary diagnosis.

Authors:  Galatea Kallergi; Oliver Hoffmann; Ann-Kathrin Bittner; Lina Papadimitriou; Spyridoula D Katsarou; Nefeli Zacharopoulou; Michalis Zervakis; Stelios Sfakianakis; Christos Stournaras; Vassilis Georgoulias; Rainer Kimmig; Sabine Kasimir-Bauer
Journal:  Ther Adv Med Oncol       Date:  2020-04-28       Impact factor: 8.168

9.  Liquid biopsy: from discovery to clinical implementation.

Authors:  Catherine Alix-Panabières; Klaus Pantel
Journal:  Mol Oncol       Date:  2021-06       Impact factor: 6.603

Review 10.  In vitro Models of Breast Cancer Metastatic Dormancy.

Authors:  Marco Montagner; Erik Sahai
Journal:  Front Cell Dev Biol       Date:  2020-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.